<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39114821</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19.</ArticleTitle><Pagination><StartPage>1392169</StartPage><MedlinePgn>1392169</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1392169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1392169</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Short-term clinical outcomes from SARS-CoV-2 infection are generally favorable. However, 15-20% of patients report persistent symptoms of at least 12&#x2009;weeks duration, often referred to as long COVID. Population studies have also demonstrated an increased risk of incident diabetes and cardiovascular disease at 12&#x2009;months following infection. While imaging studies have identified multi-organ injury patterns in patients with recovered COVID-19, their respective contributions to the disability and morbidity of long COVID is unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multicenter, observational study of 215 vaccine-na&#xef;ve patients with clinically recovered COVID-19, studied at 3-6&#x2009;months following infection, and 133 healthy volunteers without prior SARS-CoV-2 infection. Patients with recovered COVID-19 were screened for long COVID related symptoms and their impact on daily living. Multi-organ, multi-parametric magnetic resonance imaging (MRI) and circulating biomarkers were acquired to document sub-clinical organ pathology. All participants underwent pulmonary function, aerobic endurance (6&#x2009;min walk test), cognition testing and olfaction assessment. Clinical outcomes were collected up to 1&#x2009;year from infection. The primary objective of this study is to identify associations between organ injury and disability in patients with long-COVID symptoms in comparison to controls. As a secondary objective, imaging and circulating biomarkers with the potential to exacerbate cardiovascular health were characterized.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Long-term sequelae of COVID-19 are common and can result in significant disability and cardiometabolic disease. The overall goal of this project is to identify novel targets for the treatment of long COVID including mitigating the risk of incident cardiovascular disease.</AbstractText><AbstractText Label="STUDY REGISTRATION" NlmCategory="UNASSIGNED">clinicaltrials.gov (MOIST late cross-sectional study; NCT04525404).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Paterson, White, Beaulieu, Sherrington, Prado, Tandon, Halloran, Smith, McCombe, Ritchie, Pituskin, Haykowsky, Coulden, Emery, Tsui, Wu, Oudit, Ezekowitz and Thompson.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>D Ian</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>University of Ottawa Heart Institute, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherrington</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Carla M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Agricultural, Food and Nutritional Science, Faculty of Agricultural, Life and Environmental Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Puneeta</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halloran</LastName><ForeName>Kieran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCombe</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pituskin</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>College of Health Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haykowsky</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>College of Health Sciences, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coulden</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emery</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Albert K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kai Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudit</LastName><ForeName>Gavin Y</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezekowitz</LastName><ForeName>Justin A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04525404</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">circulating biomarkers</Keyword><Keyword MajorTopicYN="N">functional assessment</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">recovered COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39114821</ArticleId><ArticleId IdType="pmc">PMC11303169</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1392169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fisman DN, Tuite AR. Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario. Canada CMAJ. (2021) 193:E1619&#x2013;25. doi: 10.1503/cmaj.211248, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211248</ArticleId><ArticleId IdType="pmc">PMC8562985</ArticleId><ArticleId IdType="pubmed">34610919</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Ontario . Public health Ontario omicron severity estimates. (2022), (cited 2022 Nov 30). Available at: https://www.publichealthontario.ca/-/media/documents/ncov/epi/covid-19-epi-enhanced-estimates-omicron-severity-study.pdf?sc_lang=en</Citation></Reference><Reference><Citation>COVID-19 Immunity Task Force . Seroprevalence in Canada. (2023) (cited 2024 Feb 5), Available at: https://www.covid19immunitytaskforce.ca/seroprevalence-in-canada/</Citation></Reference><Reference><Citation>McAlister FA, Dong Y, Chu A, Wang X, Youngson E, Quinn KL, et al. . The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario. Can Med Assoc J. (2022) 194:E666&#x2013;73. doi: 10.1503/cmaj.220272, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.220272</ArticleId><ArticleId IdType="pmc">PMC9438727</ArticleId><ArticleId IdType="pubmed">35577377</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian COVID-19 Antibody and Health Survey . Frequency and impact of longer-term symptoms following COVID-19 in Canadian adults. (2023) (cited 2023 Jul 18). Available from: Frequency and Impact of Longer-Term Symptoms Following COVID-19 in Canadian Adults</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi: 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, Banerjee A. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol. (2022) 19:287&#x2013;8. doi: 10.1038/s41569-022-00697-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="pubmed">35332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Lamicchane S, Maralakunte M, Debi U, Dhooria S, Sehgal I, et al. . Role of MRI in the evaluation of pulmonary sequel following COVID-19 acute respiratory distress syndrome (ARDS). Curr Probl Diagn Radiol. (2023) 52:117&#x2013;24. doi: 10.1067/j.cpradiol.2022.09.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/j.cpradiol.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9508699</ArticleId><ArticleId IdType="pubmed">36253228</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddell T, Namburete AIL, Duckworth P, Eichert N, Thomaides-Brears H, Cuthbertson DJ, et al. . Bayesian networks and imaging-derived phenotypes highlight the role of fat deposition in COVID-19 hospitalisation risk. Front Bioinform. (2023) 3:1163430. doi: 10.3389/fbinf.2023.1163430, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbinf.2023.1163430</ArticleId><ArticleId IdType="pmc">PMC10244647</ArticleId><ArticleId IdType="pubmed">37293292</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. (2021) 31:100683. doi: 10.1016/j.eclinm.2020.100683, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. (2021) 11:e048391. doi: 10.1136/bmjopen-2020-048391, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillie JK, Lone NI, Jones S, Shaw A, Hairsine B, Kurasz C, et al. . Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. Lancet Respir Med. (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615263</ArticleId><ArticleId IdType="pubmed">37748493</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:1265. doi: 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, et al. . Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. (2021) 42:1866&#x2013;78. doi: 10.1093/eurheartj/ehab075, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosier R, Kafil TS, Paterson DI. Imaging for cardiovascular complications of COVID-19: cardiac manifestations in context. Can J Cardiol. (2023) 39:779&#x2013;92. doi: 10.1016/j.cjca.2023.01.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.01.022</ArticleId><ArticleId IdType="pmc">PMC9886397</ArticleId><ArticleId IdType="pubmed">36731604</ArticleId></ArticleIdList></Reference><Reference><Citation>Treit S, Rickard JN, Stolz E, Solar K, Seres P, Emery D, et al. . A normative brain MRI database of Neurotypical participants from 5 to 90 years of age. Can J Neurol Sci. (2023) 50:282&#x2013;6. doi: 10.1017/cjn.2021.513, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2021.513</ArticleId><ArticleId IdType="pubmed">34974849</ArticleId></ArticleIdList></Reference><Reference><Citation>Dintica CS, Marseglia A, Rizzuto D, Wang R, Seubert J, Arfanakis K, et al. . Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. (2019) 92:e700&#x2013;9. doi: 10.1212/WNL.0000000000006919, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006919</ArticleId><ArticleId IdType="pmc">PMC6382360</ArticleId><ArticleId IdType="pubmed">30651382</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. (2002) 166:111&#x2013;7. doi: 10.1164/ajrccm.166.1.at1102, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.166.1.at1102</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. (2012) 18:914&#x2013;24. doi: 10.1177/1352458512444498</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458512444498</ArticleId><ArticleId IdType="pubmed">22740603</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. (2004) 52:141&#x2013;6. doi: 10.1002/mrm.20110</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.20110</ArticleId><ArticleId IdType="pubmed">15236377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang ZP. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med. (2008) 59:571&#x2013;80. doi: 10.1002/mrm.21522, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.21522</ArticleId><ArticleId IdType="pmc">PMC3538139</ArticleId><ArticleId IdType="pubmed">18306409</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudry RI, Kirkham AA, Thompson RB, Grenier JG, Mackey JR, Haykowsky MJ. Exercise intolerance in anthracycline-treated breast Cancer survivors: the role of skeletal muscle bioenergetics, oxygenation, and composition. Oncologist. (2020) 25:e852&#x2013;60. doi: 10.1634/theoncologist.2019-0777, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2019-0777</ArticleId><ArticleId IdType="pmc">PMC7216432</ArticleId><ArticleId IdType="pubmed">31951302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. (1998) 85:115&#x2013;22. doi: 10.1152/jappl.1998.85.1.115, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1998.85.1.115</ArticleId><ArticleId IdType="pubmed">9655763</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. (2008) 33:997&#x2013;1006. doi: 10.1139/H08-075, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/H08-075</ArticleId><ArticleId IdType="pubmed">18923576</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RB, Chow K, Mager D, Pagano JJ, Grenier J. Simultaneousproton densityfat&#x2010;fraction andimaging with water&#x2010;specificT1mapping (PROFIT1): application in liver. Magn Reson Med. (2021) 85:223&#x2013;38. doi: 10.1002/mrm.28434, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28434</ArticleId><ArticleId IdType="pubmed">32754942</ArticleId></ArticleIdList></Reference><Reference><Citation>Larmour S, Chow K, Kellman P, Thompson RB. Characterization of T1 bias in skeletal muscle from fat in MOLLI and SASHA pulse sequences: quantitative fat-fraction imaging with T1 mapping. Magn Reson Med. (2017) 77:237&#x2013;49. doi: 10.1002/mrm.26113, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26113</ArticleId><ArticleId IdType="pubmed">26860524</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RB, Sherrington R, Beaulieu C, Kirkham A, Paterson DI, Seres P, et al. . Reference values for water-specific T1 of the liver at 3&#x2009;T: T2*-compensation and the confounding effects of fat. J Magn Reson Imaging. (2024) 2:29262. doi: 10.1002/jmri.29262, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.29262</ArticleId><ArticleId IdType="pubmed">38305588</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadus WQ, Stobbe RW, Grenier JG, Beaulieu C, Thompson RB. Quantification of lung water density with UTE Yarnball MRI. Magn Reson Med. (2021) 86:1330&#x2013;44. doi: 10.1002/mrm.28800, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28800</ArticleId><ArticleId IdType="pubmed">33811679</ArticleId></ArticleIdList></Reference><Reference><Citation>Keen C, Seres P, Grenier J, Stobbe R, Paterson I, Punithakumar K, et al. . Deep learning segmentation of lung parenchyma for UTE proton MRI. Proc Intl Soc Mag Reson Med. (2023), 1654</Citation></Reference><Reference><Citation>Valli&#xe8;res M., RADIOMICS. Available at: https://www.mathworks.com/matlabcentral/fileexchange/51948-radiomics; (2017)</Citation></Reference><Reference><Citation>Yu PJ, Cassiere H, Bocchieri K, DeRosa S, Yar S, Hartman A. Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: a case series. Metabol Open. (2020) 7:100046. doi: 10.1016/j.metop.2020.100046, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2020.100046</ArticleId><ArticleId IdType="pmc">PMC7382710</ArticleId><ArticleId IdType="pubmed">32808941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu PJ, Cassiere H, DeRosa S, Bocchieri K, Yar S, Hartman A. Hypermetabolism and coronavirus disease 2019. JPEN J Parenter Enteral Nutr. (2020) 44:1234&#x2013;6. doi: 10.1002/jpen.1948, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jpen.1948</ArticleId><ArticleId IdType="pmc">PMC7323185</ArticleId><ArticleId IdType="pubmed">32559309</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittle J, Molinger J, MacLeod D, Haines K, Wischmeyer PE, Whittle J, et al. . Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19. Crit Care. (2020) 24:581. doi: 10.1186/s13054-020-03286-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03286-7</ArticleId><ArticleId IdType="pmc">PMC7521195</ArticleId><ArticleId IdType="pubmed">32988390</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell SA, Elliott SA, Baracos VE, Chu QSC, Sawyer MB, Mourtzakis M, et al. . Accuracy of resting energy expenditure predictive equations in patients with Cancer. Nutr Clin Pract. (2019) 34:922&#x2013;34. doi: 10.1002/ncp.10374, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ncp.10374</ArticleId><ArticleId IdType="pubmed">31347209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W, et al. . Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am J Clin Nutr. (2010) 92:1369&#x2013;77. doi: 10.3945/ajcn.2010.29885, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2010.29885</ArticleId><ArticleId IdType="pmc">PMC2980962</ArticleId><ArticleId IdType="pubmed">20962155</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. . Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. (2023) 329:1934&#x2013;46. doi: 10.1001/jama.2023.8823, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>